What We're Reading: Page 214
Industry reads hand-picked by our editors
Mar 06, 2020
-
POLITICO
How the drug industry got its way on the coronavirus
-
MM&M
Bristol Myers Squibb unveils new branding, will phase out Celgene brand
-
Bloomberg
The Search for New Drugs for Coronavirus Faces Long Odds
-
The Wall Street Journal
Sanofi, Fighting Back in Insulin Price Debate, Says Its Net Prices Fell 11%
Mar 05, 2020
-
MIT Technology Review
Gene sleuths are tracking the coronavirus outbreak as it happens
-
Axios
Big Pharma is on a stock buyback spree
-
The Wall Street Journal
Recruitment Begins for First Test of Experimental Coronavirus Vaccine
-
STAT
Vertex battles Canada over access to cystic fibrosis treatments
Mar 04, 2020
-
The Washington Post
Why Facebook is filled with pharmaceutical ads
-
The New York Times
As Coronavirus Disrupts Factories, India Curbs Exports of Key Drugs
-
STAT
Passage Bio went public during the stock market’s worst week since 2008
-
Reuters
China approves use of Roche drug in battle against coronavirus complications
Mar 03, 2020
-
POLITICO
'You don't want to go to war with a president'
-
Bloomberg
Novartis' Sandoz Settles U.S. Drug Price-Fixing Charges
-
The Wall Street Journal
Insulin Giant Aims to Unlock Elusive Obesity-Drug Market
-
Endpoints News
Vertex, Seattle Genetics, Alpine withdraw from investor conference as biotechs brace for coronavirus
Mar 02, 2020
-
Axios
CDC lab for coronavirus test kits may have been contaminated
-
LifeSciVC
BioPharma M&A Drives More Efficient Resource Allocation
-
Endpoints News
Corporate development chief hits the exit at Biogen as aducanumab jitters roll on
-
Bloomberg
Chinese Biotech Censured for False Claim on Gilead’s Virus Drug
Feb 28, 2020
-
Forbes
Billionaire Robert Duggan’s New Biotech Chapter: An Antibiotics Quest
-
Xconomy
Biohaven's Migraine Pill Is the Latest CGRP Drug to Win the FDA's OK
-
Philadelphia Business Journal
Philadelphia gene therapy developer Passage Bio set to go public this week
-
ProPublica
Key Missteps at the CDC Have Set Back Its Ability to Detect the Potential Spread of Coronavirus
Feb 27, 2020
-
POLITICO
Trump puts Pence in charge of coronavirus response
-
Consumer Reports
GoodRx Shares Data With Google, Facebook & Others
-
FierceBiotech
Spark's CMO set to leave as post-Roche takeover exits continue
-
MIT Technology Review
If DNA is like software, can we just fix the code?
Previous
